--- topic: "Weight Loss" title: "Weight Loss Without Drugs: What Works" order: 1 description: "Which eating plans, habits and supports produce lasting weight loss, why regain is common, and when weight-loss medicines are a reasonable option." question: "What actually works for weight loss without drugs, and when are medications reasonable?" answer: "Any diet you can stick with probably produces similar, modest weight loss; regain is common, and medication suits some people." actions: - "Pick a sustainable pattern: in 609 adults over 12 months, healthy low-fat and low-carb diets lost similar weight (5.3 versus 6.0 kg); neither genes nor insulin response predicted success [2]." - "Join a structured program if you can: the US Preventive Services Task Force recommends intensive, multicomponent behavioral programs for adults with a BMI of 30 or more [3]." - "Protect your sleep and eat mostly unprocessed food: adults sleeping about 1.2 hours longer ate roughly 270 kcal less a day [6], and ultra-processed diets added about 500 kcal [4]." cautions: - "Crash diets backfire: a year after a 10-week very-low-energy diet, appetite hormones stayed off baseline and hunger stayed higher [7]; on diabetes or blood-pressure medicines, ask your clinician first." - "Weight-loss medicines like semaglutide need ongoing use: a year after stopping, people regained two-thirds of lost weight [9]; ask a clinician if BMI is 30+ (27+ with related condition) [8]." - "These trials enrolled adults: children, teens and pregnant or breastfeeding women need medical advice before dieting, and unintended weight loss is a warning sign (see [when to see a doctor](/when-to-see-a-doctor/when-home-remedies-are-not-enough))." confidence: 4 confidenceNote: "Many randomized trials and meta-analyses agree that diet type matters little and that support helps, but most trials last a year or less and long-term maintenance data are thinner." evidenceSummary: rctCount: 7 observationalCount: 1 metaAnalysisCount: 1 totalParticipants: "15,000+ across trials" replicated: true newestStudyYear: 2022 references: - id: "1" pmid: "25182101" title: "Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis" authors: "Johnston BC, Kanters S, Bandayrel K, et al." year: 2014 journal: "JAMA" - id: "2" pmid: "29466592" title: "Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial" authors: "Gardner CD, Trepanowski JF, Del Gobbo LC, et al." year: 2018 journal: "JAMA" - id: "3" pmid: "30326502" title: "Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement" authors: "Curry SJ, Krist AH, Owens DK, et al. (US Preventive Services Task Force)" year: 2018 journal: "JAMA" - id: "4" pmid: "31105044" title: "Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake" authors: "Hall KD, Ayuketah A, Brychta R, et al." year: 2019 journal: "Cell Metab" - id: "5" pmid: "25926512" title: "The role of protein in weight loss and maintenance" authors: "Leidy HJ, Clifton PM, Astrup A, et al." year: 2015 journal: "Am J Clin Nutr" - id: "6" pmid: "35129580" title: "Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings: A Randomized Clinical Trial" authors: "Tasali E, Wroblewski K, Kahn E, et al." year: 2022 journal: "JAMA Intern Med" - id: "7" pmid: "22029981" title: "Long-term persistence of hormonal adaptations to weight loss" authors: "Sumithran P, Prendergast LA, Delbridge E, et al." year: 2011 journal: "N Engl J Med" - id: "8" pmid: "33567185" title: "Once-Weekly Semaglutide in Adults with Overweight or Obesity" authors: "Wilding JPH, Batterham RL, Calanna S, et al." year: 2021 journal: "N Engl J Med" - id: "9" pmid: "35441470" title: "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension" authors: "Wilding JPH, Batterham RL, Davies M, et al." year: 2022 journal: "Diabetes Obes Metab" - id: "10" pmid: "35443107" title: "Calorie Restriction with or without Time-Restricted Eating in Weight Loss" authors: "Liu D, Huang Y, Huang C, et al." year: 2022 journal: "N Engl J Med" - id: "11" pmid: "24307184" title: "Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study" authors: "Look AHEAD Research Group" year: 2014 journal: "Obesity (Silver Spring)" - id: "12" pmid: "19127177" title: "American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults" authors: "Donnelly JE, Blair SN, Jakicic JM, et al." year: 2009 journal: "Med Sci Sports Exerc" --- Which diet you choose matters less than keeping to it: low-fat and low-carbohydrate plans produced similar loss [1][2]. Structured support helps [3], and so do fewer ultra-processed foods [4], enough protein [5] and more sleep [6]. Regain is common because appetite hormones stay altered [7]. Medicines such as semaglutide work better, but they need to continue [8][9]. ## How it works ### Why the scale fights back Weight loss needs an energy deficit, but your body resists it. In 50 adults who lost 13.5 kg on a 10-week very-low-energy diet, leptin, peptide YY and insulin stayed lower, ghrelin stayed higher and hunger stayed greater a year later [7]. Regain reflects biology, not weak will. ### Which diet: the one you keep A network meta-analysis of 48 randomized trials (7,286 adults) found that low-carbohydrate and low-fat diets each beat no diet by about 7 kg at 12 months, with minimal differences between named diets [1]. In DIETFITS, 609 adults lost 5.3 kg on a healthy low-fat diet and 6.0 kg on a healthy low-carbohydrate diet over 12 months [2]. ### Levers that help - **Food quality.** In a 4-week inpatient trial, 20 adults ate about 508 kcal a day more on an ultra-processed diet than on an unprocessed one, gaining 0.9 kg versus losing 0.9 kg, even though meals were matched for presented calories, sugar, sodium and fiber [4]. See [ultra-processed food](/ultra-processed-food/are-ultra-processed-foods-harmful). - **Protein and fiber.** Diets with 1.2 to 1.6 g of protein per kg a day, at least 25 to 30 g per meal, modestly improved fullness and weight, mainly in people who stuck to them [5]. - **Sleep.** Overweight adults who slept about 1.2 hours more ate 270 kcal a day less [6]. See [why sleep matters](/sleep/why-sleep-matters). - **Meal timing.** Eating only between 8 am and 4 pm on top of calorie restriction gave no significant extra loss over calorie restriction alone [10]. - **Support.** In adults with type 2 diabetes, intensive lifestyle support kept a 4.7 percent average weight loss at 8 years, against 2.1 percent with diabetes education alone [11]. - **Movement.** 150 to 250 minutes a week prevents gain but gives only modest loss; more than 250 minutes is linked to clinically significant loss and better maintenance [12]. See [walking](/walking/most-underrated-exercise). ### Where medication fits Semaglutide 2.4 mg weekly plus lifestyle advice cut weight 14.9 percent versus 2.4 percent with placebo over 68 weeks in 1,961 adults without diabetes who had a BMI of 30 or more (or 27 or more with a related condition) [8]. A year after stopping, two-thirds of the loss had returned [9]. For food-based ways to support your own GLP-1, see [natural ways to boost GLP-1](/glp-1/natural-boost). ## The evidence in detail ### Diet type Johnston and colleagues pooled 59 articles on 48 trials. Compared with no diet, low-carbohydrate diets produced 8.73 kg of loss at 6 months and 7.25 kg at 12 months, and low-fat diets 7.99 and 7.27 kg. Differences between named diets were minimal (Atkins beat Zone by 1.71 kg at 6 months). Behavioral support added 3.23 kg at 6 months but 1.08 kg at 12 months (95% interval -1.82 to 3.96), while exercise added 0.64 kg at 6 months and 2.13 kg at 12 months [1]. DIETFITS randomized 609 adults aged 18 to 50 (BMI 28 to 40, no diabetes) to 22 small-group sessions over 12 months. Of them, 79 percent finished; the between-diet difference was 0.7 kg (95% CI -0.2 to 1.6), and neither a genotype pattern nor insulin secretion predicted who did better on which diet [2]. ### Food, sleep and timing Hall's trial put 20 weight-stable adults at the NIH on ultra-processed and unprocessed diets, 2 weeks each in random order. Intake was 508 kcal a day higher on the ultra-processed diet (carbohydrate and fat rose; protein did not), and weight changes tracked intake (r=0.8) [4]. In Tasali's trial of 80 adults aged 21 to 40 with overweight and habitual sleep under 6.5 hours, counseling that extended sleep by about 1.2 hours cut energy intake by 270 kcal a day (95% CI 147 to 393) with no change in expenditure, so weight fell [6]. Liu's trial randomized 139 adults with obesity to calorie restriction with or without 8 am to 4 pm eating. At 12 months weight fell 8.0 kg versus 6.3 kg (net difference -1.8 kg, 95% CI -4.0 to 0.4; P=0.11) [10]. ### Why maintenance is hard Sumithran's 50 participants lost 13.5 kg in 10 weeks. At 62 weeks leptin, peptide YY, cholecystokinin, insulin, ghrelin and other mediators still differed significantly from baseline, and hunger was higher [7]. In Look AHEAD, 5,145 adults with type 2 diabetes and overweight were randomized to intensive lifestyle intervention or education only. At year 8 they had lost 4.7 and 2.1 percent of body weight; 50.3 versus 35.7 percent kept off at least 5 percent, and 26.9 versus 17.2 percent at least 10 percent [11]. The US Preventive Services Task Force found moderate benefit from intensive, multicomponent programs and from maintenance programs, with small or no harms [3]. The American College of Sports Medicine notes that no well-designed randomized trial shows exercise prevents regain, though observational data link more than 250 minutes a week to better maintenance [12]. ### Medication as the honest comparator STEP 1 randomized 1,961 adults to semaglutide 2.4 mg or placebo, both with lifestyle advice, for 68 weeks. Weight fell 14.9 versus 2.4 percent (difference 12.4 points, 95% CI 11.5 to 13.4); 86.4 versus 31.5 percent lost at least 5 percent, and 50.5 versus 4.9 percent at least 15 percent. Nausea and diarrhea were most common, and 4.5 percent versus 0.8 percent stopped for stomach side effects. The company funded the trial [8]. In the off-treatment extension of 327 participants, those on semaglutide had lost 17.3 percent by week 68 and regained 11.6 points by week 120, leaving a net 5.6 percent loss; cardiometabolic gains drifted back toward baseline [9]. ### Conflicting and null results Time-restricted eating did not beat plain calorie restriction [10]. Higher-protein diets help in tightly controlled short studies, but long-term studies are limited and conflicting, with benefit mainly in adherers [5]. Behavioral support's edge faded by 12 months in the meta-analysis [1]. Sleep extension was tested in adults with overweight, not obesity [6]. ### Bottom line Confidence is fairly high (4 of 5). Diet type matters little [1][2], structured support, food quality and sleep help [3][4][6], and regain is biologically driven [7]. Medication is more potent but works only while taken [8][9]; the choice belongs with a clinician. For weight loss with type 2 diabetes, see [type 2 diabetes and remission](/type-2-diabetes/can-type-2-diabetes-be-reversed-naturally).